Atlas Trials

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration

Clinical trial NCT00395707 · COMPLETED

Trial details

NCT number
NCT00395707
Sponsor
The National Retina Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2005-08-01
Primary completion
2008-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.